Cisco DNA Advantage On-Premise License 200M 1-Year | Enterprise — DNA-P-100M-A-1Y

Keep Cisco DNA Advantage coverage aligned to your on-premise deployment model with a 1-year aggregate license for 200M capacity. This entitlement is suited to teams that want precise software coverage without overcommitting to a longer term than the project or budget requires. For infrastructure groups managing staged rollouts, capacity-based licensing can be easier to map to actual deployment scope. The 200M aggregate designation gives procurement and architecture teams a clear planning unit, while the 1-year term keeps the commitment tight for environments that change quickly or are being validated in phases. That makes it a practical fit for controlled rollouts, refresh programs, and organizations that prefer annual review cycles for software spend. Cisco DNA Advantage is typically chosen when the access or network environment needs a higher licensing tier than basic coverage. In an on-premise context, that can help teams keep entitlement aligned to operational policy and reduce ambiguity during audits or renewals. For buyers comparing options, this license offers a focused way to secure Cisco software coverage for a defined capacity and timeframe. Ideal For Annual licensing for on-premise Cisco network deployments with defined capacity Phased infrastructure rollouts that require short-term entitlement control Budget-managed refresh programs that review software spend every 12 months Controlled enterprise environments that need Cisco DNA Advantage coverage on-premise Why This Product 1 1-year term supports annual budgeting and review cycles 2 200M aggregate capacity gives a defined planning unit 3 On-premise licensing fits controlled deployment environments 4 Cisco DNA Advantage tier supports higher-value network entitlement